Search Results - "Rousell, Victoria M."

Metabolism and Disposition of Fluticasone Furoate, an Enhanced-Affinity Glucocorticoid, in Humans by HUGHES, Stephen C, SHARDLOW, Peter C, HOLLIS, Frank J, SCOTT, Rebecca J, MOTIVARAS, Dimple S, ALIEN, Ann, ROUSELL, Victoria M

“…The purpose of this study was to investigate the metabolism and disposition of fluticasone furoate, an enhanced-affinity glucocorticoid receptor agonist, in…”
Get full text

Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria by Lacerda, Marcus V.G, Llanos-Cuentas, Alejandro, Krudsood, Srivicha, Lon, Chanthap, Saunders, David L, Mohammed, Rezika, Yilma, Daniel, Batista Pereira, Dhelio, Espino, Fe E.J, Mia, Reginaldo Z, Chuquiyauri, Raul, Val, Fernando, Casapía, Martín, Monteiro, Wuelton M, Brito, Marcelo A.M, Costa, Mônica R.F, Buathong, Nillawan, Noedl, Harald, Diro, Ermias, Getie, Sisay, Wubie, Kalehiwot M, Abdissa, Alemseged, Zeynudin, Ahmed, Abebe, Cherinet, Tada, Mauro S, Brand, Françoise, Beck, Hans-Peter, Angus, Brian, Duparc, Stephan, Kleim, Jörg-Peter, Kellam, Lynda M, Rousell, Victoria M, Jones, Siôn W, Hardaker, Elizabeth, Mohamed, Khadeeja, Clover, Donna D, Fletcher, Kim, Breton, John J, Ugwuegbulam, Cletus O, Green, Justin A, Koh, Gavin C.K.W

“…Clearing of the dormant liver stage (the hypnozoite) of P. vivax malaria is important to prevent the relapse of infection. In this randomized clinical trial, a…”
Get full text

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria by Llanos-Cuentas, Alejandro, Lacerda, Marcus V.G., Hien, Tran T., Vélez, Iván D., Namaik-larp, Chayadol, Chu, Cindy S., Villegas, Maria F., Val, Fernando, Monteiro, Wuelton M., Brito, Marcelo A.M., Costa, Mônica R.F., Chuquiyauri, Raul, Casapía, Martín, Nguyen, Chau H., Aruachan, Sandra, Papwijitsil, Ratchadaporn, Nosten, François H., Bancone, Germana, Angus, Brian, Duparc, Stephan, Craig, Graham, Rousell, Victoria M., Jones, Siôn W., Hardaker, Elizabeth, Clover, Donna D., Kendall, Lindsay, Mohamed, Khadeeja, Koh, Gavin C.K.W., Wilches, Viviana M., Breton, John J., Green, Justin A.

Get full text

Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial by Vélez, Iván D, Hien, Tran T, Green, Justin A, Martin, Ana, Sharma, Hema, Rousell, Victoria M, Breton, John J, Ernest, Terry B, Rolfe, Katie, Taylor, Maxine, Mohamed, Khadeeja, Jones, Siôn W, Chau, Nguyen Hoang, Hoa, Nhu Thi, Duparc, Stephan, Tan, Lionel K, Goyal, Navin

“…Single-dose tafenoquine 300 mg is approved for Plasmodium vivax malaria relapse prevention in patients at least 16 years old. We aimed to determine appropriate…”
Get more information

Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria by Llanos-Cuentas, Alejandro, Lacerda, Marcus V.G, Hien, Tran T, Vélez, Iván D, Namaik-larp, Chayadol, Chu, Cindy S, Villegas, Maria F, Val, Fernando, Monteiro, Wuelton M, Brito, Marcelo A.M, Costa, Mônica R.F, Chuquiyauri, Raul, Casapía, Martín, Nguyen, Chau H, Aruachan, Sandra, Papwijitsil, Ratchadaporn, Nosten, François H, Bancone, Germana, Angus, Brian, Duparc, Stephan, Craig, Graham, Rousell, Victoria M, Jones, Siôn W, Hardaker, Elizabeth, Clover, Donna D, Kendall, Lindsay, Mohamed, Khadeeja, Koh, Gavin C.K.W, Wilches, Viviana M, Breton, John J, Green, Justin A

“…Malaria remains a global health burden. Elimination of the hypnozoite is required in patients infected with P. vivax to prevent relapse. In this report, the…”
Get full text